National Breast Cancer and Lymphedema Registry
NCT01580800 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 549
Last updated 2018-06-29
Summary
The purpose of the National Breast Cancer Lymphedema Registry is to collect health information in order to study the lymphedema as a complication of breast cancer treatment. The investigators hope to learn whether early diagnosis will help to prevent lymphedema or, if it does occur, to reduce the severity.
Conditions
- Breast Cancer
- Lymphedema
Sponsors & Collaborators
-
Stanley Rockson
lead OTHER
Principal Investigators
-
Stanley G Rockson · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-12
- Primary Completion
- 2018-03-02
- Completion
- 2018-03-02
Countries
- United States
Study Locations
More Related Trials
-
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
NCT00058058 ·Status: COMPLETED ·Phase: NA
-
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
NCT00695968 ·Status: TERMINATED
-
Histologic Diagnoses of Incidentally Detected Lesions on MRI
NCT00579735 ·Status: WITHDRAWN
-
Use of Breast MRI for Local Staging
NCT00579319 ·Status: WITHDRAWN
-
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment
NCT04803084 ·Status: SUSPENDED
-
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening
NCT03861975 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging of Breast Cancer
NCT01035112 ·Status: RECRUITING ·Phase: NA
-
Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates
NCT01166581 ·Status: TERMINATED
-
Study in Patients With Breast Cancer Leptomeningeal Metastasis
NCT06638294 ·Status: RECRUITING
-
Magnetic Resonance Imaging in Patients With Breast Cancer
NCT00610181 ·Status: COMPLETED
-
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661 ·Status: COMPLETED
-
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 ·Status: WITHDRAWN
-
Screening For BCRL In Targeted Therapy For Breast Cancer
NCT05142800 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer
NCT06580743 ·Status: COMPLETED
-
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics
NCT05826197 ·Status: UNKNOWN
-
Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images
NCT06510738 ·Status: NOT_YET_RECRUITING
-
Discordant Hormonal Status of Breast Cancer.
NCT01943032 ·Status: COMPLETED
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema
NCT01599039 ·Status: COMPLETED
-
Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer
NCT06001528 ·Status: RECRUITING
-
Establishing an Inflammatory Breast Cancer Registry
NCT00340158 ·Status: COMPLETED
-
Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer
NCT04322331 ·Status: UNKNOWN
-
Studying Normal Breast Tissue and Cancer Risk
NCT00341692 ·Status: COMPLETED
-
An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya
NCT01484483 ·Status: COMPLETED
-
Breast Cancer Registry in Thailand
NCT01541878 ·Status: UNKNOWN